Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioCryst Pharmaceuticals, an integrated biopharmaceutical company, has elected Stanley Erck to its board of directors. Mr Erck has over 20 years of experience in the biotechnology industry, most recently serving as president and CEO at Iomai in Gaithersburg, Maryland.
Subscribe to our email newsletter
Prior to Iomai, he served as president and CEO of Procept, a publicly traded immunology company, as vice president, corporate development at Integrated Genetics (now Genzyme), and in management positions within Baxter International.
Mr Erck received his undergraduate degree from the University of Illinois and his MBA from the University of Chicago Graduate School of Business.
Jon Stonehouse, president and CEO of BioCryst Pharmaceuticals, said: “We are pleased to welcome Mr Erck to our board of directors. Stan’s experience in leading biotech companies and his knowledge of managing a large advanced development contract from the Department of Health and Human Services will be of great value to BioCryst as the company advances its clinical pipeline.”